L-NAME Reduces Tumor Growth and Capillary Leakage in Mice
Author Information
Author(s): A Orucevic, PK Lala
Primary Institution: The University of Western Ontario
Hypothesis
Can NG-nitro-L-arginine methyl ester (L-NAME) prevent interleukin 2-induced capillary leakage in tumor-bearing mice without compromising the therapeutic benefits of IL-2?
Conclusion
L-NAME effectively reduced tumor growth and the severity of IL-2-induced capillary leakage in some organs without compromising the anti-tumor efficacy of IL-2 therapy.
Supporting Evidence
- L-NAME significantly reduced IL-2-induced pulmonary edema and water retention in the spleen.
- L-NAME therapy alone did not induce pleural effusion in any of the animals.
- Addition of L-NAME to IL-2 therapy did not compromise the anti-tumor effects of IL-2.
Takeaway
L-NAME is a medicine that helps stop leaks in blood vessels caused by another medicine called IL-2, which helps fight cancer. It also helps shrink tumors.
Methodology
C3H/HeJ female mice were treated with IL-2 and various doses of L-NAME, and the effects on capillary leakage and tumor growth were measured.
Limitations
Some animals died from IL-2 toxicity, affecting the sample size for the second round of therapy.
Participant Demographics
C3H/HeJ female mice, 6-7 weeks old.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website